GPs in England have voted to re-enter dispute with the government from 1 October over plans to allow […]
The Global Fund to Fight AIDS, Tuberculosis, and Malaria was established in 2002 as an international financing mechanism […]
BMJ journalists have won three prizes at the 2025 Medical Journalists’ Association (MJA) awards this week, including for […]
Vimseltinib becomes first authorised therapy for tenosynovial giant cell tumour in the EU
Preclinical results highlight potential of glycosaminoglycan-based therapy
bmj;390/sep18_1/r1921/FAF1fa“To fully understand our patients, we ideally need to have shared experience with them,” paediatric trainee Sophie Jackson […]
Mahase quotes her colleague’s experience at work related to their hearing impairment.1 The story is very similar to […]
bmj;390/sep17_1/r1946/FAF1faDavid Isaacs was considered the father of paediatric infectious diseases in Australia and New Zealand12 but he is […]
Doctors refusing to use “untried and untested” artificial intelligence (AI) software at work will be supported by the […]
The arrival of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide and tirzepatide marks an important moment […]